Granules Consumer Health, a manufacturer of over-the-counter and prescription pharmaceuticals, announced this week that it will invest $1.5 million to expand its operations in Prince William County.
The company will install new manufacturing lines at its existing facility, creating 99 new jobs.
“We are excited to partner with Prince William County and to have chosen Manassas as home for our new packaging facility,” said Krishna Prasad Chigurupati, chairman and managing director of Granules India Limited. “Since its opening in early 2023, we have nearly doubled our workforce by hiring local talent. This is a big step forward for us, and we are glad to be growing alongside the community.”
Granules Consumer Health specializes in the manufacturing of generic drug products that provide alternatives to brand-name drugs.
The expansion will allow the company to add more complex manufacturing capabilities for over-the-counter drugs, including acetaminophen, ibuprofen and other OTC medications.
“When we welcomed Granules to the Commonwealth in 2022, we knew we were bringing best-in-class to Virginia,” Gov. Glenn Youngkin said. “Nearly two years later, Granules’ decision to expand their operations reinforces Virginia’s position as a cutting-edge hub for advanced pharmaceutical manufacturing. This investment not only creates 99 new jobs, but underscores the Commonwealth’s commitment to supporting businesses that drive innovation in healthcare and life sciences.”
Support AFP
Share
Chris Graham
